Research platform
Research platform of Noxi Lab allows generating original hybrid molecules from endogenous bioregulators, pharmacologically active compounds and nitric oxide donors (NO-donors)
Main News
* Gurus successfully completed preclinical trials of asthma treatment drug * Magazine Kommersant published an article about promising multifunctional drug candidates of Gurus BioPharm * Gurus raises $0.7M for preclinical trials of a drug for asthma

Team

Partners of Gurus have together more than 45 years of experience in the pharmaceutical industry, finance and management.

Igor Teterin

Partner, founder


Igor Teterin has 10 years of experience in the biopharmaceutical industry, 20 years of managerial and entrepreneurial experience. Mr. Teterin initiated and co-founded Gurus BioPharm in 2011 to run two synergetic businesses: development of innovative drugs and investments in life sciences startups at the early stage. Igor Teterin is a co-founder of technological startup Noxi Lab, which develops a nitric oxide-donating research platform for generating innovative drugs.
In 2005 Igor created a consulting company Gurus Capital, from 2005 to 2010 has accomplished more than 10 projects for pharmaceutical companies in valuation of drug candidates, due diligence, business valuation, marketing research in pharmaceutical industry. Mr. Teterin has developed a financial model for evaluating drug candidates on preclinical and clinical stages based on MS Excel.
Mr. Teterin received a DBA, Doctor of Business Administration in corporate finance in 2007 and an MBA in marketing in 2004 from California State University, Hayward. Igor has been an expert of Skolkovo since 2011, and accomplished more than 50 examinations of projects in life sciences. Igor Teterin graduated National Research University MAI in 1991, specializing in mathematics.

Igor Lyubimov, Ph.D.

CEO, partner


Igor Lyubimov - has more than 25 years of managerial and scientific experience in biotechnology and pharmacology, long-term experience in preclinical and clinical trials. 
Since 2011 Igor has been a co-founder and CEO of Gurus BioPharm, which is which develops and finance biopharmaceutical innovations starting from early stage. Igor Lyubimob is a co-founder of technological startup Noxi Lab, which develops a nitric oxide-donating research platform for generating innovative drugs. In 2010-2011 has worked with private life sciences venture firms and contract research organizations on executive positions. Until 2008 Igor led microbiological studies at the State Research Center for Applied Microbiology and Biotechnology.
Mr. Lyubimov got Ph.D. in biology in Lomonosov Moscow State University in 1995. Igor Lybimov graduated Mechnikov St-Petersburg Medical Academy in 1988 specializing in epidemiology. Igor is an expert of Skolkovo, and has accomplished more than 100 examinations of projects in life sciences.